Abstract
The present study aimed to analyze, in the period from 2016 to 2020, the evolution of spending by the Ministry of Health to comply with judicial determinations that sought the right to health, focusing on rare diseases, and the influence of Conitec’s analyzes on them. The documentary analysis took into consideration the amounts spent, the list of medicines that spent the most resources, which technologies were evaluated by the Commission, the stablished deliberations for them, and how they have influenced judicial decisions. It was found that despite of the fact that Conitec carries out a rigorous Health Technology Assessment (HTA) process and directs efforts to make its actions and recommendations accessible, there seems to be a lack of engagement by Law Operators to understand how the incorporation of health technologies into Brazilian Public Health System (SUS) occurs. Similarly, some kind of distancing and lack of interlocution between these two instances are implied. In view of the specificity of the theme, which requires not only legal knowledge, but also the assessment of health technologies, it is understood as a possible solution the approximation between Executive and Judiciary Powers, so that they share knowledge and exchange of experience and judicialization can serve as an instrument to guarantee rights laid down in the Constitution and infra-constitutional norms
Todo o conteúdo dos artigos publicados no JAFF está licenciado sob uma Licença Creative Commons Atribuição 4.0 Internacional, que permite o uso, compartilhamento, adaptação, distribuição e reprodução em qualquer meio ou formato, desde que você dê o devido crédito ao autor(es) original(ais) e a fonte, fornecer um link para a licença Creative Commons e indicar se alterações foram feitas. As imagens ou outros materiais de terceiros neste artigo estão incluídos na licença Creative Commons do artigo, salvo indicação em contrário em uma linha de crédito para o material.
